Isabell Pekrul
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 29, 2024
Primary presentation and clinical course of pediatric and adolescent patients with differentiated thyroid carcinoma after radioiodine therapy.
Journal: Frontiers in oncology
Published: June 09, 2023
Tranexamic acid: the importance of correct use and individualized risk-benefit analysis
Journal: Der Anaesthesist
Published: May 10, 2021
A novel approach to laboratory assessment and reporting of platelet von Willebrand factor.
Journal: Platelets
Published: January 11, 2021
Approximation of emicizumab plasma levels in emergency situations. A practical approach.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 26, 2020
Persistent inhibitor in acquired haemophilia A: A case for emicizumab?
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 26, 2020
The Role of Therapeutic Anticoagulation in COVID-19.
Journal: Case reports in critical care
Published: May 23, 2020
Laboratory testing in hemophilia: Impact of factor and non-factor replacement therapy on coagulation assays.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 21, 2019
Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia A.
Journal: Thrombosis and haemostasis
Published: June 17, 2019
Last Updated: 09/26/2026